Contact
The financial newspaper Expansión devotes three news items to the investment made by Ysios Capital in the IRB Barcelona/ICREA biotech company Inbiomotion.
Read the PDF in Expansión (PDF in Spanish)
Link to Expansión newspaper
Link to the IRB Barcelona news
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
